Efficacy and safety of vardenafil in the treatment of erectile dysfunction in men with hypertension.
- Author:
Hong-Jun LI
1
Author Information
1. Department of Urology, Peking Union Hospital, Beijing 100730, China. hongjun63@163.com
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Erectile Dysfunction;
complications;
drug therapy;
Humans;
Hypertension;
complications;
Imidazoles;
adverse effects;
therapeutic use;
Male;
Middle Aged;
Phosphodiesterase Inhibitors;
adverse effects;
therapeutic use;
Piperazines;
adverse effects;
therapeutic use;
Sulfones;
adverse effects;
therapeutic use;
Treatment Outcome;
Triazines;
adverse effects;
therapeutic use;
Vardenafil Dihydrochloride
- From:
National Journal of Andrology
2006;12(10):953-956
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence of erectile dysfunction (ED) is higher in hypertension patients than in non-hypertension men. Because doctors worry about the severe adverse events of drug combination, they tend to be reluctant to prescribe ED medicines for patients. Vardenafil, as a novel and highly selective phosphodiesterase 5 inhibitor, has been proved by many clinical trials to be quite safe for the cardiovascular system. A recent large-scale clinical trial showed that vardenafil could improve erectile function in ED men with hypertension, with sure safety and no significant clinical changes in the index of hypertension or heart rate.
